These include the Cobas EGFR mutation test V2, which can identify EGFR mutations in non-small cell lung cancer, and the Therascreen PIK3CA RGQ PCR kit, which can identify PIK3CA mutations in breast cancer [170]. Here, EGFR is linked to breast carcinoma.